Paper39734809
A machine learning-assisted systematic review of preclinical glioma modeling: Is practice changing with the times?
Hirst TC and 3 others. Neurooncol Adv, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. A machine learning-assisted systematic review of preclinical glioma modeling: Is practice changing with the times? Papers, record 39734809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39734809
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A machine learning-assisted systematic review of preclinical glioma modeling: Is practice changing with the times?
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33585240 | Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments. | Front Oncol | 2020 | https://conductscience.org/library/papers/33585240 | PubMed |
| 2 | 26479923 | High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. | Nat Med | 2015 | https://conductscience.org/library/papers/26479923 | PubMed |
| 3 | 18813876 | What is the translational efficacy of chemotherapeutic drug research in neuro-oncology? A systematic review and meta-analysis of the efficacy of BCNU and CCNU in animal models of glioma. | J Neurooncol | 2009 | https://conductscience.org/library/papers/18813876 | PubMed |
| 4 | 21336775 | Optimization of glioblastoma multiforme stem cell isolation, transfection, and transduction. | J Neurooncol | 2011 | https://conductscience.org/library/papers/21336775 | PubMed |
| 5 | 19381449 | Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. | J Neurooncol | 2009 | https://conductscience.org/library/papers/19381449 | PubMed |
| 6 | 31068700 | Next-generation characterization of the Cancer Cell Line Encyclopedia. | Nature | 2019 | https://conductscience.org/library/papers/31068700 | PubMed |
| 7 | 26629530 | The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes. | EBioMedicine | 2015 | https://conductscience.org/library/papers/26629530 | PubMed |
| 8 | 20126413 | U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line. | PLoS Genet | 2010 | https://conductscience.org/library/papers/20126413 | PubMed |
| 9 | 32102678 | The necessity for standardization of glioma stem cell culture: a systematic review. | Stem Cell Res Ther | 2020 | https://conductscience.org/library/papers/32102678 | PubMed |
| 10 | 35922758 | Characterization and comparison of human glioblastoma models. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35922758 | PubMed |
| 11 | 20823880 | Finding the tumor copycat. Therapy fails, patients don't. | Nat Med | 2010 | https://conductscience.org/library/papers/20823880 | PubMed |
| 12 | 16697959 | Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. | Cancer Cell | 2006 | https://conductscience.org/library/papers/16697959 | PubMed |
| 13 | 24549183 | Systematic reviews and meta-analysis of preclinical studies: why perform them and how to appraise them critically. | J Cereb Blood Flow Metab | 2014 | https://conductscience.org/library/papers/24549183 | PubMed |
| 14 | 24810477 | U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells. | Cancer Med | 2014 | https://conductscience.org/library/papers/24810477 | PubMed |
| 15 | 27582061 | Origin of the U87MG glioma cell line: Good news and bad news. | Sci Transl Med | 2016 | https://conductscience.org/library/papers/27582061 | PubMed |
| 16 | 31852831 | Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma. | Clin Cancer Res | 2020 | https://conductscience.org/library/papers/31852831 | PubMed |
| 17 | 25185190 | Patient-derived xenograft models: an emerging platform for translational cancer research. | Cancer Discov | 2014 | https://conductscience.org/library/papers/25185190 | PubMed |
| 18 | 19353526 | Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. | Stem Cells | 2009 | https://conductscience.org/library/papers/19353526 | PubMed |
| 19 | 25943888 | Glioblastoma: pathology, molecular mechanisms and markers. | Acta Neuropathol | 2015 | https://conductscience.org/library/papers/25943888 | PubMed |
| 20 | 29805321 | The Cellosaurus, a Cell-Line Knowledge Resource. | J Biomol Tech | 2018 | https://conductscience.org/library/papers/29805321 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41993637 | Dual-ligand curcin-loaded hybrid solid lipid nanoparticles achieve durable gliosarcoma remission while preserving neuro-behavioral function. | Theranostics | 2026 | https://conductscience.org/library/papers/41993637 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39734809
GET https://conductscience.org/api/papers/v1/39734809/references?page=2